Clinical Trials Logo

Filter by:
NCT ID: NCT01261325 Completed - Epilepsy Clinical Trials

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

BRITE
Start date: December 2010
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of brivaracetam at doses of 100 and 200mg/day compared to placebo as adjunctive treatment in adult focal epilepsy subjects with partial onset seizures not fully controlled despite current treatment with 1 or 2 concomitant antiepileptic drugs.

NCT ID: NCT01261234 Completed - Clinical trials for In-stent Restenosis After Carotid Artery Stenting

Carotid Artery Stenting With Cilostazol Addition for Restenosis

CAS-CARE
Start date: December 2010
Phase: N/A
Study type: Interventional

CAS-CARE study was conducted to evaluate the inhibitory effect of cilostazol, compared to that of other antiplatelet drugs, on in-stent restenosis following carotid artery stenting (CAS) in patients scheduled to undergo CAS. Study design is Multicenter Prospective Ranodomized Controlled Study, rondomized by cilostazol/non-cilostazol group prior to CAS. 900 patients will be enrolled for 2 years and followed 2 years with in-stent restenosis after CAS, evaluated by carotid ultrasound and angiography.

NCT ID: NCT01259505 Completed - Clinical trials for Metastatic Breast Cancer

Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer

Start date: December 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety of HLA-A*2402 restricted epitope peptides CDCA1,URLC10,KIF20A,DEPDC1 and MPHOSPH1 emulsified with Montanide ISA 51.

NCT ID: NCT01258920 Completed - Schizophrenia Clinical Trials

A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia

Start date: October 2010
Phase: Phase 3
Study type: Interventional

The primary objective of this study is to evaluate the long-term safety and tolerability of paliperidone palmitate in Japanese patients with schizophrenia. Secondary objectives of this study are to: explore the efficacy on symptoms of schizophrenia and the maintenance of treatment effect; explore the pharmacokinetics of paliperidone palmitate through sparse pharmacokinetic sampling.

NCT ID: NCT01257269 Recruiting - Clinical trials for Thrombotic Thrombocytopenic Purpura

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

TTP registry
Start date: October 2006
Phase:
Study type: Observational

Hereditary thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) is a rare disorder characterized by thrombocytopenia as a result of platelet consumption, microangiopathic hemolytic anemia, occlusion of the microvasculature with von Willebrand factor-platelet-thrombic and ischemic end organ damage. The underlying patho-mechanism is a severe congenital ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motif, 13) deficiency which is the result of compound heterozygous or homozygous ADAMTS13 gene mutations. Although considered a monogenic disorder the clinical presentation in Upshaw-Schulman syndrome patients varies considerably without an apparent genotype-phenotype correlation. In 2006 we have initiated a registry for patients with Upshaw-Schulman syndrome and their family members to identify possible triggers of acute bouts of TTP, to document individual clinical courses and treatment requirements as well as possible side effects of long standing plasma substitution, e.g. alloantibody formation or viral infections.

NCT ID: NCT01256723 Active, not recruiting - Clinical trials for Coronary Artery Disease

Japan Unprotected Left Main Coronary Artery Disease Percutaneous Coronary Intervention (PCI) Strategy On New Generation Stents

J-LESSON
Start date: October 2010
Phase: N/A
Study type: Observational

The main purpose of this study is to observe the incidence of major adverse cardiac and cerebrovascular events (MACCE), target vessel failure (TVF), target vessel revascularization (TVR) and stent thrombosis out to 5 years after the procedure in patients who underwent percutaneous coronary intervention (PCI) with everolimus-eluting stents for unprotected left main coronary artery (ULMCA) disease and lesions involving the ULMCA in Japan. The investigators will also establish a method of adjustment to the Japanese version of the SYNTAX score by conducting an assessment using the SYNTAX score recently reported in the US and Europe as well as the EuroSCORE, and by clarifying the differences of PCI procedures and treatment results in Japan with those reported in the US and Europe.

NCT ID: NCT01256567 Completed - Breast Cancer Clinical Trials

A Study of Ramucirumab (IMC-1121B) in Participants With Breast Cancer

Start date: December 2010
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to investigate the safety and tolerability of the anti-VEGFR-2 monoclonal antibody ramucirumab drug product in combination with docetaxel in Japanese participants with metastatic, or locally advanced breast cancer, with the aim of confirming the recommended dose of ramucirumab drug product (DP) in combination with docetaxel.

NCT ID: NCT01256411 Completed - Clinical trials for Essential Hypertension

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension

Start date: November 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the long-term safety, tolerability and efficacy of LCZ696.

NCT ID: NCT01256047 Completed - Bile Duct Cancer Clinical Trials

Effects of Preoperative Immunonutrition in Patients Undergoing Hepatectomy

Start date: May 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with major hepatectomy.

NCT ID: NCT01256034 Completed - Pancreatic Cancer Clinical Trials

Effects of Preoperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy

EPIPD
Start date: May 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether preoperative immunonutrition is effective on infectious complication and Th1/Th2 differentiation in patients with pancreaticoduodenectomy.